Please assess the completion status of the following clinical trial:

Trial Title: New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* undergo chemotherapy for any one of the following settings:~  1. Setting 1: Neoadjuvant chemotherapy prior to cheom-RT~ 2. Setting 2: Palliative chemotherapy in Chemonaive patients~ 3. Setting 3: Palliative chemotherapy in previously treated patients (i.e. 2nd line or 3rd line chemo)~* Age \>= 18 years~* (ECOG) performance status of 0-2~* have detectable levels of pEBV DNA at baseline~* have measurable tumor sites by RECIST criteria~* have adequate bone marrow, renal and hepatic functions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- advanced nasopharyngeal carcinoma (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).